Feasibility and safety of endoscopic resection for duodenal gastrointestinal stromal tumors

Last Updated: Monday, September 8, 2025

This article looks at the feasibility and safety of endoscopic resection for duodenal gastrointestinal stromal tumors, detailing a retrospective study on patients who underwent either endoscopic submucosal dissection (ESD) or endoscopic full-thickness resection (EFTR). It was concluded that both ESD and EFTR are minimally invasive and safe treatments for these specific tumors, with EFTR showing potential advantages for deeper lesions.

Endoscopy International Open

Langenbeck's Archives of Surgery

Partial resection of rectum for rectal GIST by posterior approach

Clinical and Translational Medicine

Beta-elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1

Endoscopy International Open

Feasibility and safety of endoscopic resection for duodenal gastrointestinal stromal tumors

Pediatrics

Complete remission of metastatic GIST in a pediatric patient with high-dose imatinib induction

Clinical Cancer Research

Phase 2 trial of ponatinib in patients with metastatic gastrointestinal stromal tumor following failure or intolerance of prior therapy with imatinib (POETIG trial)

Oncology Letters

Prolonged survival of a case with three different malignancies - cutaneous malignant melanoma, gastrointestinal stromal tumor and thyroid papillary cancer: A case report

Pharmaceutics

Tyrosine kinase inhibitors for gastrointestinal stromal tumor after imatinib resistance

Clinical Cancer Research

Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors

Gastric Cancer

Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumors

Autophagy

Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity

Gastrointestinal Stromal Tumor Resource Center

Feasibility and safety of endoscopic resection for duodenal gastrointestinal stromal tumors

Langenbeck's Archives of Surgery

Partial resection of rectum for rectal GIST by posterior approach

Clinical and Translational Medicine

Beta-elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1

Endoscopy International Open

Feasibility and safety of endoscopic resection for duodenal gastrointestinal stromal tumors

Pediatrics

Complete remission of metastatic GIST in a pediatric patient with high-dose imatinib induction

Clinical Cancer Research

Phase 2 trial of ponatinib in patients with metastatic gastrointestinal stromal tumor following failure or intolerance of prior therapy with imatinib (POETIG trial)

Oncology Letters

Prolonged survival of a case with three different malignancies - cutaneous malignant melanoma, gastrointestinal stromal tumor and thyroid papillary cancer: A case report

Pharmaceutics

Tyrosine kinase inhibitors for gastrointestinal stromal tumor after imatinib resistance

Clinical Cancer Research

Circulating tumor DNA as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with advanced gastrointestinal stromal tumors

Gastric Cancer

Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumors

Autophagy

Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity

Addressing the Needs of a Patient with Significant Comorbidity: Newly Diagnosed GIST in the Setting of Chronic Heart Failure

Multidisciplinary Support: Addressing Communication and Access Barriers to Enhance Patient Understanding

Management of Side Effects Associated With GIST Therapies